Journals / Turkish Journal of Pediatrics / 2021 / Cilt: 63 - Sayı: 3

Pediatric hospital healthcare workers and pertussis; a seroprevalence study

Pages
355–362
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

These findings highlight the fact that pertussis can occur in adult age groups and that eradication cannot be achieved without effective adult immunization and surveillance.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:This study aimed to assess pertussis seroprevalence among healthcare workers (HCWs) of a university children’s hospital and to determine their opinions on whether to get the pertussis vaccine booster dose in adulthood.
📊
Key Findings & Data:This cross-sectional study was carried out between January 2018 and March 2019.
💡
Conclusion & Impact:These findings highlight the fact that pertussis can occur in adult age groups and that eradication cannot be achieved without effective adult immunization and surveillance.
🔬Design:Research Article
📍Scope:2018 Verileri
⚙️Variables:Domain Parameters

Özet

Background. This study aimed to assess pertussis seroprevalence among healthcare workers (HCWs) of a university children’s hospital and to determine their opinions on whether to get the pertussis vaccine booster dose in adulthood. Methods. This cross-sectional study was carried out between January 2018 and March 2019. Data recording forms were filled by the face to face interview method. Anti-pertussis toxin IgG (Anti-PT IgG) antibody levels were determined quantitatively from the serum samples using a commercial enzyme-linked immunosorbent assay (ELISA) kit. Anti-PT IgG results were interpreted according to World Health Organization (WHO) recommendations. Results. Of the 169 HCWs included in the study, 67 (39.6%) were seronegative and susceptible to pertussis. Seropositivity was significantly higher among HCWs who worked 40–80 hours per week. Thirty-six (21.3%) HCWs had high anti-PT IgG levels, indicating recent infection in the past few years. High-level positivity was significantly more common among HCWs using macrolide antibiotics due to prolonged cough. Anti-PT IgG levels of three (1.8%) were compatible with acute infection and they were not followed up with suspicion of whooping cough and were not isolated. While 125 (74.0%) of the participants said they could get the pertussis vaccine booster dose, only three (1.8%) had done so. Conclusions. The fact that 39.6% of HCWs were seronegative, emphasized the need for the pertussis booster dose. More than 20% of HCWs have had the acute infection without pertussis diagnosis in the past few years. Adult vaccination awareness in HCWs has not yet created a change in behavior. The high rate of seropositivity in macrolide users also shows that we cannot prevent its spread despite treatment. These findings highlight the fact that pertussis can occur in adult age groups and that eradication cannot be achieved without effective adult immunization and surveillance.

🔖

Cite This Article

ÖZER, S., OĞUZ, V. A. (2021). Pediatric hospital healthcare workers and pertussis; a seroprevalence study. Turkish Journal of Pediatrics, Cilt: 63 - Sayı: 3, 355–362. https://ajindex.com/articles/418848

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. World Health Organization (WHO). The immunological basis for immunization series - module 4: pertussis, update 2017. Available at: https://apps.who.int/iris/handle/10665/259388. (Accessed on May 12, 2020)
  2. Hoffait M, Hanlon D, Benninghoff B Calcoen S. Pertussis knowledge, attitude and practices among European health care professionals in charge of adult vaccination. Hum Vaccin 2011; 7: 197-201
  3. Strebel P, Nordin J, Edwards K, et al. Population‐ based incidence of pertussis among adolescents and adults, Minnesota, 1995-1996. J Infect Dis 2001; 183: 1353-1359
  4. Cherry JD. Epidemiological, clinical, and laboratory aspects of pertussis in adults. Clin Infect Dis 1999; 28(Suppl 2): S112-S117
  5. Kurugol Z. Türkiye’de boğmaca epidemiyolojisi: pekiştirme aşı dozları gerekli mi? Çocuk Enfeksiyon Dergisi 2009; 3: 14-18
  6. Pertussis vaccines: WHO position paper – August 2015. Available: https://www.who.int/wer/2015/ wer9035.pdf?ua=1. (Accessed on May 12, 2020)
  7. Urbiztondo L, Broner S, Costa J, et al; The Working Group For The Study Of The Immune Status In Health Care. Seroprevalence study of B. pertussis infection in health care workers in Catalonia, Spain. Hum Vaccin Immunother 2015; 11: 293-297
  8. Sandora TJ, Gidengil CA, Lee GM. Pertussis vaccination for health care workers. Clin Microbiol Rev 2008; 21: 426-434
  9. Liang JL, Tiwari T, Moro P, et al. Prevention of pertussis, tetanus, and diphtheria with vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2018; 67: 1-44
  10. World Health Organization, Study on global ageing and adult health (SAGE) pertussis working group. Available at: https://www.who.int/immunization/ sage/meetings/2014/april/1_Pertussis_background_ FINAL4_web.pdf?ua (Accessed on May 12, 2020)
  11. Esen B, Coplu N, Kurtoglu D, Gozalan A, Akin L. Prevalence of high antibody titers of pertussis in Turkey: reflection of circulating microorganism and a threat to infants. J Clin Lab Anal 2007; 21: 154-161
  12. Duranoglu L, Sonmez C, Vurucu S, et al. Evaluation of pertussis immunity status in schoolchildren immunized with whole-cell vaccine. Epidemiol Infect 2010; 138: 299-303
  13. Vatansever U, Coplu N, Oner N, et al. Seroprevalance of Bordetella pertussis antibodies among healthy adolescent girls in Edirne. Swiss Med Wkly 2005; 135: 531-536
  14. Tanriover MD, Soyler C, Ascioglu S, Cankurtaran M, Unal S. Low seroprevalance of diphtheria, tetanus and pertussis in ambu